What is the Actual Rate of Acute Skin Toxicity in Women Undergoing Adjuvant Radiation Therapy for Early Breast Cancer? Final Results of a Single Institution Phase II Study

被引：0
|
作者：
Niazi, T. [1 ,2 ]
Azoulay, M. [1 ]
Sultanem, K. [1 ]
Muanza, T. [1 ]
Bahoric, B. [1 ]
Faria, S. [1 ]
Vuong, T. [1 ,2 ]
机构：
[1] McGill Univ, Montreal, PQ, Canada
[2] McGill Univ, Jewish Gen Hosp, Segal Canc Ctr, Montreal, PQ H3T 1E2, Canada
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2011年 / 81卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2011.06.1703
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S239 / S239
页数：1
相关论文
共 50 条
  • [21] A Retrospective Study Evaluating Toxicity in Women With DCIS Undergoing Hypofractionated Adjuvant Radiation Therapy After Breast Conserving Surgery
    Young, R.
    Blakaj, D. M.
    Hong, L.
    Spierer, M. M.
    Mehta, K. J.
    Kalnicki, S.
    Fox, J. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S260 - S260
  • [22] Phase II randomized, placebo-controlled trial of phytotherapeutic product Catuama for breast cancer women undergoing adjuvant radiation therapy.
    Cruz, Felipe Melo
    Gomes Cubero, Daniel de Iracema
    Santi, Patricia Xavier
    Landeiro, Luciana Garcia
    Tamashiro, Andressa Sayuri
    Ribeiro, Larisse Soares
    Del Giglio, Auro
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [23] The Fitzpatrick Skin Type Scale: A reliability and validity study in women undergoing radiation therapy for breast cancer
    Fasugba, Oyebola
    Gardner, Anne
    Smyth, Wendy
    JOURNAL OF WOUND CARE, 2014, 23 (07) : 358 - 368
  • [24] Robotic Stereotactic Body Radiation Therapy for the Adjuvant Treatment of Early-Stage Breast Cancer: Outcomes of a Large Single-Institution Study
    Jaysing, Anna
    Lischalk, Jonathan W.
    Sanchez, Astrid
    Mendez, Christopher
    May, Phoebe
    Solan, Amy
    Witten, Matthew
    Logman, Zhanna
    Haas, Jonathan A.
    ADVANCES IN RADIATION ONCOLOGY, 2023, 8 (02)
  • [25] Intraoperative Radiation Therapy Prior to Lumpectomy for Early-Stage Breast Cancer: A Single Institution Study
    Ma, L.
    Yu, W.
    Ju, Z.
    Gong, H.
    Li, X.
    Zhang, Y.
    Kong, Q.
    Wang, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S135 - S135
  • [26] Correlation of breast volume and acute skin toxicity in two different radiation fraction schedules in women with early stage breast cancer
    Soulimioti, G.
    Fotopoulou, A.
    Maravelis, I.
    Tzorakakis, S.
    Gtrlemis, K.
    Theodoridou, A.
    Grigoropoulos, P.
    Athanasiou, H.
    BREAST, 2017, 32 : S72 - S72
  • [27] Phase II study assessing the effectiveness of biafine cream as a prophylactic agent for radiation-induced acute skin toxicity to the breast in women undergoing radiotherapy with concomitant CMF chemotherapy
    Szumacher, E
    Wighton, A
    Franssen, E
    Chow, E
    Tsao, M
    Ackerman, I
    Andersson, L
    Kim, J
    Wojcicka, A
    Ung, Y
    Sixel, K
    Hayter, C
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (01): : 81 - 86
  • [28] Intensity modulated radiation therapy (IMRT) decreases the acute skin toxicity for large-breasted women receiving radiation therapy for breast cancer
    Freedman, GM
    Anderson, PR
    Han, AL
    Eisenberg, D
    Nicolaou, N
    Li, J
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S401 - S402
  • [29] Ocular toxicity during adjuvant chemoendocrine therapy for early breast cancer - Results from International Breast Cancer Study Group Trials
    Gianni, L
    Panzini, I
    Li, SG
    Gelber, RD
    Collins, J
    Holmberg, SB
    Crivellari, D
    Castiglione-Gertsch, M
    Goldhirsch, A
    Coates, AS
    Ravaioli, A
    CANCER, 2006, 106 (03) : 505 - 513
  • [30] Weekly administration of bendamustine as salvage therapy in metastatic breast cancer: final results of a phase II study
    Eichbaum, Michael H. R.
    Schuetz, Florian
    Khbeis, Tanja
    Lauschner, Ilka
    Foerster, Frank
    Sohn, Christof
    Schneeweiss, Andreas
    ANTI-CANCER DRUGS, 2007, 18 (08) : 963 - 968
12345